Healthcare -
Biotechnology - NASDAQ - US
$ 19.6
1.34 %
$ 3.27 B
Market Cap
14.41
P/E
ACAD - REVENUE
Revenue ACAD - ACADIA Pharmaceuticals Inc.
726 M
LAST VALUE
22.49%
2 YEAR CAGR
26.55%
5 YEAR CAGR
90.65%
10 YEAR CAGR